Exercise Approaches and Physical Activity Level in Inactive Adults

February 11, 2026 updated by: Begum Kara Kaya, Biruni University

Effects of Different Exercise Approaches on Physical Activity Level and Health Outcomes in Inactive Adults

This randomized, controlled, single-blind study aims to compare the effects of different exercise approaches on physical activity level and health-related outcomes in inactive adults. Thirty inactive individuals aged 18-35 years will be randomly assigned to supervised face-to-face group exercise, mobile application-based exercise, or video-based home exercise. Exercise programs will be performed three days per week for eight weeks and will include aerobic, strengthening, and flexibility exercises.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zeytinburnu
      • Istanbul, Zeytinburnu, Turkey (Türkiye)
        • Recruiting
        • Biruni University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Taking fewer than 5,000 steps per day and classified as physically inactive according to the International Physical Activity Questionnaire-Short Form (<600 MET-min/week)
  • Residing in Istanbul
  • Willingness to participate in the study

Exclusion Criteria:

  • Diagnosis of end-stage congestive heart failure
  • Presence of malignant or unstable arrhythmia
  • Lack of adequate infrastructure to participate in technology-based physical activity programs
  • Presence of mental dysfunction
  • Presence of acute musculoskeletal injury
  • Pregnancy
  • Answering "YES" to any item on the Physical Activity Readiness Questionnaire (PAR-Q)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Face-to-Face Supervised Exercise
Participants will perform supervised face-to-face group exercise sessions three days per week for eight weeks under the guidance of a physiotherapist. Each session will include aerobic, strengthening, and flexibility exercises.
Experimental: Mobile App-Based Exercise
Participants will perform exercise sessions using the Nike+ Training Club mobile application three days per week for eight weeks. The program will include aerobic, strengthening, and flexibility exercises delivered through asynchronous video content.
Experimental: Home-Based Video Exercise
Participants will perform video-based home exercise sessions using the "Walk at Home: Leslie" program three days per week for eight weeks. The program will include aerobic, strengthening, and flexibility exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Physical Activity Level
Time Frame: From baseline to the end of the intervention at 8 weeks
Physical activity will be assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF). Total physical activity will be calculated as metabolic equivalent (MET)-minutes per week based on walking, moderate-intensity, and vigorous-intensity activities performed during the last 7 days. Higher values indicate higher levels of physical activity.
From baseline to the end of the intervention at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daily Step Count
Time Frame: From baseline to the end of the intervention at 8 weeks
Daily step count will be measured using a wearable activity tracker. The average number of steps per day will be recorded. Higher values indicate higher levels of physical activity. Unit of Measure is steps per day.
From baseline to the end of the intervention at 8 weeks
Active Time
Time Frame: From baseline to the end of the intervention at 8 weeks
Active time will be assessed using a wearable activity tracker. The average duration of active movement per day will be recorded. Higher values indicate greater daily physical activity duration. Unit of measure is minutes per day.
From baseline to the end of the intervention at 8 weeks
Energy Expenditure
Time Frame: From baseline to the end of the intervention at 8 weeks
Daily energy expenditure related to physical activity will be measured using a wearable activity tracker. Higher values indicate greater caloric expenditure through physical activity. Unit of Measure is kilocalories per day.
From baseline to the end of the intervention at 8 weeks
Distance Covered
Time Frame: From baseline to the end of the intervention at 8 weeks
Distance covered during daily activities will be recorded using a wearable activity tracker. Higher values indicate greater daily movement. Unit of Measure is kilometers per day.
From baseline to the end of the intervention at 8 weeks
Aerobic Capacity
Time Frame: From baseline to the end of the intervention at 8 weeks
Aerobic capacity will be assessed using the 6-Minute Walk Test. The outcome measure will be the total distance walked in meters during the six-minute test period.
From baseline to the end of the intervention at 8 weeks
Lower Extremity Muscle Strength
Time Frame: From baseline to the end of the intervention at 8 weeks
Lower extremity muscle strength will be assessed using the 1-Minute Sit-to-Stand Test. The outcome will be the total number of correctly performed sit-to-stand repetitions completed within one minute.
From baseline to the end of the intervention at 8 weeks
Health Releated Quality of Life
Time Frame: From baseline to the end of the intervention at 8 weeks
Health-related quality of life will be assessed using the Short Form-36 Health Survey (SF-36). The SF-36 consists of eight domains assessing physical and mental health. Each domain is scored on a 0-100 scale, with 0 indicating the worst health status and 100 indicating the best health status. Higher scores represent better perceived health-related quality of life.
From baseline to the end of the intervention at 8 weeks
Participant Satisfaction and Perceived Change
Time Frame: At the end of the intervention (8 weeks)
Participant satisfaction and perceived change will be assessed using the Global Rating of Change (GRC) scale. Participants will rate their perceived overall change and satisfaction with the intervention compared to baseline.
At the end of the intervention (8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2025

Primary Completion (Estimated)

March 2, 2026

Study Completion (Estimated)

March 2, 2026

Study Registration Dates

First Submitted

December 19, 2025

First Submitted That Met QC Criteria

February 11, 2026

First Posted (Actual)

February 13, 2026

Study Record Updates

Last Update Posted (Actual)

February 13, 2026

Last Update Submitted That Met QC Criteria

February 11, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PActivity

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise Training

Clinical Trials on Face-to-Face Supervised Exercise

Subscribe